Vantage Investment Advisors, LLC - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEGW and the CUSIP is 30233M115. A total of 4 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Vantage Investment Advisors, LLC ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$02,5000.0%0.00%
Q1 2018$02,5000.0%0.00%
Q4 2017$02,5000.0%0.00%
Q3 2017$02,5000.0%0.00%
Q2 2017$02,5000.0%0.00%
Q1 2017$0
-100.0%
2,5000.0%0.00%
Q4 2016$1,0000.0%2,5000.0%0.00%
Q3 2016$1,0002,5000.0%0.00%
Q2 2016$0
-100.0%
2,5000.0%0.00%
-100.0%
Q1 2016$2,0000.0%2,5000.0%0.00%0.0%
Q4 2015$2,000
-33.3%
2,5000.0%0.00%
-50.0%
Q3 2015$3,0002,5000.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 137,092$7,0000.00%
CVI Holdings, LLC 12,900$00.00%
UBS Group AG 4,300$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders